Tag Archives: J.B. Hunt Transport Services Inc

Wait before trading on company earnings

CNBC’s Jim Cramer on Friday warned investors not to make trading decisions fresh off a company’s earnings report.

Stocks made a comeback on Friday after falling initially on quarterly earnings reports and recession warnings from major banks. All three major indexes ended the week up, as investors digested a slate of earnings reports and economic data that suggested inflation is cooling. 

Cramer, who earlier this week offered investors a set of guidelines for earnings season, called Friday’s trading session an example of why investors should be disciplined with their portfolios.

“Every quarter I make the same argument about how you should wait and do more work before you pull the trigger, but a lot of people remain unconvinced,” he said.

He also went over next week’s slate of quarterly reports. All estimates for earnings, revenue and economic data are courtesy of FactSet.

Tuesday: Goldman Sachs, Morgan Stanley, United Airlines

Goldman Sachs

  • Q4 2022 earnings release at 7:30 a.m. ET; conference call at 9:30 a.m. ET
  • Projected EPS: $5.56
  • Projected revenue: $10.76 billion

The company’s stock could soar higher if the earnings report beats expectations, he said.

Morgan Stanley

  • Q4 2022 earnings release at 7:30 a.m. ET; conference call at 8:30 a.m. ET
  • Projected EPS: $1.29
  • Projected revenue: $12.54 billion

Cramer said he expects a “terrific” report from the bank.

United Airlines

  • Q4 2022 earnings release at 4:30 p.m. ET; conference call on Wednesday at 10:30 a.m. ET
  • Projected EPS: $2.11
  • Projected revenue: $12.23 billion

The company will put up great numbers, since consumers are still spending on travel, he predicted.

Wednesday: J.B. Hunt Transport, Alcoa

J.B. Hunt Transport

  • Q4 2022 earnings release before the bell; conference call at 9 a.m. ET
  • Projected EPS: $2.45
  • Projected revenue: $3.83 billion

Cramer said he’ll be watching for any sign that there’s a slowdown in commerce.

Alcoa

  • Q4 2022 earnings release at 4:10 p.m. ET; conference call at 5 p.m. ET
  • Projected loss: 69 cents per share
  • Projected revenue: $2.65 billion

The metals “have become insane stock growers. … The aluminum company knows if the metals move is merely a squeeze or the real deal with actual demand,” he said.

Thursday: Procter & Gamble, Netflix

Procter & Gamble

  • Q2 2023 earnings release at 6:55 a.m. ET; conference call at 8:30 a.m. ET
  • Projected EPS: $1.58
  • Projected revenue: $20.70 billion

He said he expects the company to report a solid quarter as raw costs come down and foreign exchange headwinds abated.

Netflix

  • Q4 2022 earnings release at 4 p.m. ET; conference call at 6 p.m. ET
  • Projected EPS: 58 cents
  • Projected revenue: $7.84 billion

“I think Netflix could be one of the strongest stories out there,” he said.

Friday: SLB

  • Q4 2022 earnings release at 7 a.m. ET; conference call at 9:30 a.m. ET
  • Projected EPS: 68 cents
  • Projected revenue: $7.78 billion

“SLB will tell us where the new finds are. They will play with an open hand. I bet you they give you a little update on Russia, too,” he said.

Disclaimer: Cramer’s Charitable Trust owns shares of Morgan Stanley and Procter & Gamble.

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.

Read original article here

Netflix, Las Vegas Sands and more

The Netflix logo is seen on their office in Hollywood, California.

Lucy Nicholson | Reuters

Check out the companies making headlines in midday trading.

Netflix — Shares of the streaming company popped 4.4% a day after Netflix posted a smaller-than-expected subscriber loss in the recent quarter. Netflix reported a beat on earnings but a miss on revenue.

Casino stocks — Shares of Las Vegas Sands and Wynn Resorts rose 3.3% and 2.3%, respectively. The action followed a report from Reuters that Macau will reopen casinos on Saturday as it gradually eases back on Covid restrictions.

Bath & Body Works — Bath & Body Works’ shares slipped more than 1% after the personal care retailer trimmed its guidance for the second quarter and full year. The company cited macroeconomic issues among the reason for the cut.

Baker Hughes — Shares plunged more than 8% after the oilfield services company reported disappointing second-quarter earnings. Baker Hughes reported earnings of 11 cents per share, which is half of what analysts were expecting, according to consensus estimates from Refinitiv.

Biogen —  Shares of the biopharmaceutical company fell more than 5% despite the company reporting a beat on quarterly earnings and revenue. Biogen said it faces increasing generic and biosimilar competition for its Tecfidera and Rituxan drugs.

Merck — Merck shares slipped 2.7% after the company’s cancer therapy drug did not meet its goal in a late-stage trial in patients with head and neck cancer.

Nasdaq — Shares of the exchange operator jumped 5.2% on the back of an earnings beat on the top and bottom lines. Nasdaq reported earnings of $2.07 per share on revenue of $893 million.

J.B. Hunt Transport Services — Shares of J.B. Hunt dipped about 1.7% despite a stronger-than-expected report for the recent quarter. The company’s chief operating officer said that the labor and equipment markets remain “challenging.” The transportation company reported $2.42 in earnings per share on $3.84 billion of revenue. Analysts surveyed by Refinitiv had penciled in $2.35 in earnings per share on $3.60 billion of revenue.

Elevance Health — Elevance shares tumbled more than 8% despite a beat on earnings and revenue in the recent quarter. The company, formerly known as Anthem, also raised its full-year guidance.

— CNBC’s Tanaya Macheel, Sarah Min and Jesse Pound contributed reporting

Read original article here

Get ready for the climb. Here’s what history says about stock-market returns during Fed rate-hike cycles.

Bond yields are rising again so far in 2022. The U.S. stock market seems vulnerable to a bona fide correction. But what can you really tell from a mere two weeks into a new year? Not much and quite a lot.

One thing feels assured: the days of making easy money are over in the pandemic era. Benchmark interest rates are headed higher and bond yields, which have been anchored at historically low levels, are destined to rise in tandem.

Read: Weekend reads: How to invest amid higher inflation and as interest rates rise

It seemed as if Federal Reserve members couldn’t make that point any clearer this past week, ahead of the traditional media blackout that precedes the central bank’s first policy meeting of the year on Jan. 25-26.

The U.S. consumer-price and producer-price index releases this week have only cemented the market’s expectations of a more aggressive or hawkish monetary policy from the Fed.

The only real question is how many interest-rate increases will the Federal Open Market Committee dole out in 2022. JPMorgan Chase & Co.
JPM,
-6.15%
CEO Jamie Dimon intimated that seven might be the number to beat, with market-based projections pointing to the potential for three increases to the federal funds rate in the coming months.

Check out: Here’s how the Federal Reserve may shrink its $8.77 trillion balance sheet to combat high inflation

Meanwhile, yields for the 10-year Treasury note yielded 1.771% Friday afternoon, which means that yields have climbed by about 26 basis points in the first 10 trading days to start a calendar year, which would be the briskest such rise since 1992, according to Dow Jones Market Data. Back 30 years ago, the 10-year rose 32 basis points to around 7% to start that year.

The 2-year note
TMUBMUSD02Y,
0.960%,
which tends to be more sensitive to the Fed’s interest rate moves, is knocking on the door of 1%, up 24 basis points so far this year, FactSet data show.

But do interest rate increases translate into a weaker stock market?

As it turns out, during so-called rate-hike cycles, which we seem set to enter into as early as March, the market tends to perform strongly, not poorly.

In fact, during a Fed rate-hike cycle the average return for the Dow Jones Industrial Average
DJIA,
-0.56%
is nearly 55%, that of the S&P 500
SPX,
+0.08%
is a gain of 62.9% and the Nasdaq Composite
COMP,
+0.59%
has averaged a positive return of 102.7%, according to Dow Jones, using data going back to 1989 (see attached table). Fed interest rate cuts, perhaps unsurprisingly, also yield strong gains, with the Dow up 23%, the S&P 500 gaining 21% and the Nasdaq rising 32%, on average during a Fed rate hike cycle.

Dow Jones Market Data

Interest rate cuts tend to occur during periods when the economy is weak and rate hikes when the economy is viewed as too hot by some measure, which may account for the disparity in stock market performance during periods when interest-rate reductions occur.

To be sure, it is harder to see the market producing outperformance during a period in which the economy experiences 1970s-style inflation. Right now, it feels unlikely that bullish investors will get a whiff of double-digit returns based on the way stocks are shaping up so far in 2022. The Dow is down 1.2%, the S&P 500 is off 2.2%, while the Nasdaq Composite is down a whopping 4.8% thus far in January.

Read: Worried about a bubble? Why you should overweight U.S. equities this year, according to Goldman

What’s working?

So far this year, winning stock market trades have been in energy, with the S&P 500’s energy sector
SP500.10,
+2.44%

XLE,
+2.35%
looking at a 16.4% advance so far in 2022, while financials
SP500.40,
-1.01%

XLF,
-1.04%
are running a distant second, up 4.4%. The other nine sectors of the S&P 500 are either flat or lower.

Meanwhile, value themes are making a more pronounced comeback, eking out a 0.1% weekly gain last week, as measured by the iShares S&P 500 Value ETF
IVE,
-0.14%,
but month to date the return is 1.2%.

See: These 3 ETFs let you play the hot semiconductor sector, where Nvidia, Micron, AMD and others are growing sales rapidly

What’s not working?

Growth factors are getting hammered thus far as bond yields rise because a rapid rise in yields makes their future cash flows less valuable. Higher interest rates also hinder technology companies’ ability to fund stock buy backs. The popular iShares S&P 500 Growth ETF
IVW,
+0.28%
is down 0.6% on the week and down 5.1% in January so far.

What’s really not working?

Biotech stocks are getting shellacked, with the iShares Biotechnology ETF
IBB,
+0.65%
down 1.1% on the week and 9% on the month so far.

And a popular retail-oriented ETF, the SPDR S&P Retail ETF
XRT,
-2.10%
tumbled 4.1% last week, contributing to a 7.4% decline in the month to date.

And Cathie Wood’s flagship ARK Innovation ETF
ARKK,
+0.33%
finished the week down nearly 5% for a 15.2% decline in the first two weeks of January. Other funds in the complex, including ARK Genomic Revolution ETF
ARKG,
+1.04%
and ARK Fintech Innovation ETF
ARKF,
-0.99%
are similarly woebegone.

And popular meme names also are getting hammered, with GameStop Corp.
GME,
-4.76%
down 17% last week and off over 21% in January, while AMC Entertainment Holdings
AMC,
-0.44%
sank nearly 11% on the week and more than 24% in the month to date.

Gray swan?

MarketWatch’s Bill Watts writes that fears of a Russian invasion of Ukraine are on the rise, and prompting analysts and traders to weigh the potential financial-market shock waves. Here’s what his reporting says about geopolitical risk factors and their longer-term impact on markets.

Week ahead

U.S. markets are closed in observance of the Martin Luther King Jr. holiday on Monday.

Read: Is the stock market open on Monday? Here are the trading hours on Martin Luther King Jr. Day

Notable U.S. corporate earnings

(Dow components in bold)
TUESDAY:

Goldman Sachs Group
GS,
-2.52%,
Truist Financial Corp.
TFC,
+0.96%,
Signature Bank
SBNY,
+0.07%,
PNC Financial
PNC,
-1.33%,
J.B. Hunt Transport Services
JBHT,
-1.04%,
Interactive Brokers Group Inc.
IBKR,
-1.22%

WEDNESDAY:

Morgan Stanley
MS,
-3.58%,
Bank of America
BAC,
-1.74%,
U.S. Bancorp.
USB,
+0.09%,
State Street Corp.
STT,
+0.32%,
UnitedHealth Group Inc.
UNH,
+0.27%,
Procter & Gamble
PG,
+0.96%,
Kinder Morgan
KMI,
+1.82%,
Fastenal Co.
FAST,
-2.55%

THURSDAY:

Netflix
NFLX,
+1.25%,
United Airlines Holdings
UAL,
-2.97%,
American Airlines
AAL,
-4.40%,
Baker Hughes
BKR,
+4.53%,
Discover Financial Services
DFS,
-1.44%,
CSX Corp.
CSX,
-0.82%,
Union Pacific Corp.
UNP,
-0.55%,
The Travelers Cos. Inc. TRV, Intuitive Surgical Inc. ISRG, KeyCorp.
KEY,
+1.16%

FRIDAY:

Schlumberger
SLB,
+4.53%,
Huntington Bancshares Inc.
HBAN,
+1.73%

U.S. economic reports

Tuesday

  • Empire State manufacturing index for January due at 8:30 a.m. ET
  • NAHB home builders index for January at 10 a.m.

Wednesday

  • Building permits and starts for December at 8:30 a.m.
  • Philly Fed Index for January at 8:30 a.m.

Thursday

  • Initial jobless claims for the week ended Jan. 15 (and continuing claims for Jan. 8) at 8:30 a.m.
  • Existing home sales for December at 10 a.m.

Friday

Leading economic indicators for December at 10 a.m.

Read original article here

Travelers, Halliburton, IBM, PPG & more

Check out the companies making headlines before the bell:

Travelers – The insurance company earned $3.45 per share for its second quarter, easily beating the consensus estimate of $2.39. Revenue also topped forecasts, with Travelers benefiting from higher premiums, improved investment returns and lower catastrophe losses. 

Nasdaq – Nasdaq shares rose 1% in the premarket after the exchange operator announced plans to spin out its Nasdaq Private Market, its platform for private company shares, into a separate company. It will do so in partnership with a group of banks including Citigroup, Morgan Stanley and Goldman Sachs.

Halliburton – Halliburton jumped more than 2% in premarket trading, after beating estimates by 3 cents with quarterly earnings of 26 cents per share. The oilfield services company posted its second straight quarterly profit as rebounding oil prices boosted demand.

IBM – IBM beat estimates by 4 cents with adjusted quarterly earnings of $2.33 per share, while revenue beat estimates as well. IBM’s revenue increase of 3.4% from year-earlier levels was its strongest in 3 years, helped by IBM’s cloud and software businesses. IBM jumped roughly 3.5% in premarket action.

PPG Industries – PPG earned an adjusted $1.94 per share for its latest quarter, falling short of the $2.19 consensus estimate, though the paint and coatings maker did see revenue slightly above Wall Street forecasts. PPG also warned that input and other costs would increase during the current quarter. PPG tumbled roughly 6.5% in the premarket.

Johnson & Johnson, McKesson, Cardinal Health, AmerisourceBergen – U.S. states are expected to announce a $26 billion settlement this week with companies accused of fueling a nationwide opioid epidemic, according to multiple reports. The settlement would involve payments from drug maker J&J as well as the three drug distributors. McKesson jumped more than 5% in the premarket, with Cardinal Health adding 4.5%. 

Comcast, ViacomCBS – Comcast CEO Brian Roberts and ViacomCBS Chair Shari Redstone in recent weeks discussed a possible international streaming partnership, according to people familiar with the matter who spoke to the Wall Street Journal. ViacomCBS gained 1.3% in premarket trading, with Comcast up 0.1%.

Zions Bancorp – Zions earned $2.08 per share for the second quarter, well above the consensus estimate of $1.29, with the bank’s revenue topping Street forecasts as well. Its results were boosted by a reversal of pandemic-related loan loss provisions, among other factors. The company said future credit-related losses will be significantly less than previously expected. 

JB Hunt Transport – JB Hunt Transport came in 4 cents ahead of estimates with quarterly earnings of $1.61 per share, while the logistics company’s revenue also beat estimates. The company saw strong freight demand across all its segments during the quarter.

Crown Holdings – Crown Holdings reported adjusted quarterly earnings of $2.15 per share, compared to a consensus estimate of $1.78, with the maker of packaging products for consumer goods also seeing revenue top Wall Street forecasts. Its performance was helped in part by strong demand in the beverage can segment. Crown shares jumped nearly 4% in the premarket.

Read original article here